Skip to content
The Policy VaultThe Policy Vault

leniolisib phosphateBlue Cross Blue Shield of Illinois

other FDA labeled or compendia-supported indications (Ohio members only)

Initial criteria

  • 1. The member resides in Ohio AND
  • 2. The plan is Fully Insured or HIM Shop (SG) AND BOTH of the following:
  • A. The patient does NOT have any FDA labeled contraindications to the requested agent AND
  • B. ONE of the following:
  • 1. The patient has another FDA labeled indication for the requested agent and route of administration OR
  • 2. The patient has another indication that is supported in compendia for the requested agent and route of administration OR
  • 3. The prescriber has submitted TWO articles from major peer-reviewed professional medical journals supporting the proposed use(s) as generally safe and effective (accepted study designs may include randomized, double blind, placebo controlled clinical trials; case studies are not acceptable)

Approval duration

12 months